Results for tag: "Ipatasertib"

Ipatasertib is a drug used in the treatment of breast cancer. It is a type of targeted therapy, which works by blocking the activity of a protein called AKT. This protein is involved in the growth and spread of cancer cells. Ipatasertib is used in combination with other drugs to treat certain types of breast cancer, such as hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. It is also used to treat certain types of non-small cell lung cancer. Ipatasertib is available in tablet form and is taken orally. It is usually taken once daily, with or without food. Common side effects of the drug include nausea, diarrhea, fatigue, and low white blood cell count. The market for Ipatasertib is growing as more patients are being diagnosed with breast cancer and other forms of cancer. The drug is being used in combination with other drugs to treat certain types of cancer, making it an important part of cancer treatment. Companies in the Ipatasertib market include AstraZeneca, Merck, Pfizer, and Novartis. Show Less Read more